Published in Clin Neurol Neurosurg on October 01, 1997
Precision Bypass in Patients With Moyamoya Disease (PBM) | NCT03516851
Surgical revascularisation for childhood moyamoya. Childs Nerv Syst (2012) 1.51
Age-specific eNOS polymorphisms in moyamoya disease. Childs Nerv Syst (2011) 1.46
Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst (2005) 1.42
Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings. J Neurosurg (2013) 1.14
Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry (2006) 1.14
Moyamoya disease in adults: the role of cerebral revascularization. Skull Base (2005) 1.07
Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep (2014) 1.04
RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke (2014) 1.04
Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One (2012) 1.00
Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. J Stroke (2016) 0.99
Moyamoya disease in children. Childs Nerv Syst (2010) 0.95
Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet (2015) 0.95
Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst (2004) 0.90
Research on intracranial atherosclerosis from the East and west: why are the results different? J Stroke (2014) 0.90
Clinical features of familial moyamoya disease. Childs Nerv Syst (2005) 0.90
Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans. J Korean Neurosurg Soc (2009) 0.88
Missing relationship of moyamoya and persistent primitive artery in Europeans. Another distinctive feature or artifact? Surg Radiol Anat (2015) 0.88
Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in Moyamoya disease: A review of the literature. Surg Neurol Int (2012) 0.86
Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg (2012) 0.85
Research Progress of Moyamoya Disease in Children. Int J Med Sci (2015) 0.84
Clinical and immunopathological features of Moyamoya disease. PLoS One (2012) 0.83
Electroencephalography in pediatric moyamoya disease: reappraisal of clinical value. Childs Nerv Syst (2013) 0.82
Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst (2004) 0.81
Case Report: A case report of Moyamoya disease in a 36 year old African American woman. F1000Res (2014) 0.80
Is there a role for treating inflammation in moyamoya disease?: a review of histopathology, genetics, and signaling cascades. Front Neurol (2013) 0.80
Histopathological Characteristics of Distal Middle Cerebral Artery in Adult and Pediatric Patients with Moyamoya Disease. Neurol Med Chir (Tokyo) (2016) 0.79
Moyamoya disease and pregnancy: case reports and criteria for successful vaginal delivery. Clin Case Rep (2015) 0.78
Adult unilateral moyamoya disease with familial occurrence in two definite cases: a case report and review of the literature. Neurosurg Rev (2005) 0.78
Long-term Outcome of Motor Function in a Child with Moyamoya Disease: A Case Report. J Phys Ther Sci (2014) 0.78
'Smoke in the air': a rare cerebrovascular cause of neurological signs and symptoms in a young adult. J Community Hosp Intern Med Perspect (2015) 0.78
Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data. J Korean Neurosurg Soc (2015) 0.78
Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst (2004) 0.76
Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-up. J Stroke Cerebrovasc Dis (2015) 0.76
Variant angina in moyamoya disease--a correlative etiology and different presentation: a case report. J Med Case Rep (2015) 0.76
Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS. BMC Neurol (2010) 0.76
Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease. AJNR Am J Neuroradiol (2014) 0.76
CO2BOLD assessment of moyamoya syndrome: Validation with single photon emission computed tomography and positron emission tomography imaging. World J Radiol (2016) 0.75
Cerebrovascular disease and stroke in Korean male adolescent. Yonsei Med J (2012) 0.75
Ivy Sign in Moyamoya Disease. Eurasian J Med (2016) 0.75
Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study). BMJ Open (2016) 0.75
The Contrast Enhancement of Intracranial Arterial Wall on High-resolution MRI and Its Clinical Relevance in Patients with Moyamoya Vasculopathy. Sci Rep (2017) 0.75
Comparative analysis of serum proteomes of moyamoya disease and normal controls. J Korean Neurosurg Soc (2010) 0.75
Incidence and long-term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan. Cancer Med (2016) 0.75
Moyamoya disease in pregnancy: management after intracranial bypass grafting. Case Rep Obstet Gynecol (2012) 0.75
Single Nucleotide Polymorphism in Patients with Moyamoya Disease. J Korean Neurosurg Soc (2015) 0.75
Outcome of revascularization in moyamoya disease: Evaluation of a new angiographic scoring system. Asian J Neurosurg (2015) 0.75
Moyamoya disease - a vasculopahty and an uncommon cause of recurrent cerebrovascular accidents. J Radiol Case Rep (2008) 0.75
Clinical and angiographic findings in Moya Moya. Am J Case Rep (2014) 0.75
Intermittent Hemiplegia in a Boy with Primary Moyamoya Disease: A Case Report from Iran. Iran J Child Neurol (2017) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
A role for ghrelin in the central regulation of feeding. Nature (2001) 8.12
Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature (1987) 6.66
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Regulation of PTEN transcription by p53. Mol Cell (2001) 5.44
Circulating activated endothelial cells in sickle cell anemia. N Engl J Med (1997) 5.13
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology (2000) 4.27
Electric-field control of ferromagnetism. Nature (2001) 4.15
Proximal impact of two first-grade preventive interventions on the early risk behaviors for later substance abuse, depression, and antisocial behavior. Am J Community Psychol (1999) 3.98
Control of pollen tube tip growth by a Rop GTPase-dependent pathway that leads to tip-localized calcium influx. Plant Cell (1999) 3.32
Understanding the clinical dilemmas that shape medical students' ethical development: questionnaire survey and focus group study. BMJ (2001) 3.23
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene (2006) 3.18
Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science (1984) 3.17
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab (2001) 3.16
Tannins and human health: a review. Crit Rev Food Sci Nutr (1998) 3.03
The action of proteolytic enzymes on N,N-dimethyl proteins. Basis for a microassay for proteolytic enzymes. J Biol Chem (1969) 2.94
The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity (2000) 2.93
Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol (1993) 2.90
Angiotropic lymphoma with histologic features of neoplastic angioendotheliomatosis presenting with predominant respiratory and hematologic manifestations. Report of a case and review of the literature [corrected]. Am J Clin Pathol (1990) 2.77
Acquired Chiari I malformation and syringomyelia associated with bilateral chronic subdural hematoma. Case report. J Neurosurg (1995) 2.75
Quantum Hall effect in polar oxide heterostructures. Science (2007) 2.73
Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg (1997) 2.65
Hyperglycemic pseudohypoxia and diabetic complications. Diabetes (1993) 2.62
Circadian waves of expression of the APRR1/TOC1 family of pseudo-response regulators in Arabidopsis thaliana: insight into the plant circadian clock. Plant Cell Physiol (2000) 2.61
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol (2011) 2.54
Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg (1981) 2.53
Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol (2000) 2.49
Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol (2000) 2.49
Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab (2000) 2.43
Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun (2000) 2.42
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J (1995) 2.41
Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun (2000) 2.41
Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40
Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med (1994) 2.38
Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem (2000) 2.37
The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32
Tracheal intubation through the intubating laryngeal mask airway (LMA-Fastrach) in patients with difficult airways. Anaesth Intensive Care (1998) 2.31
Passive smoking and lung cancer. Lancet (1983) 2.27
Japan collaborative cohort study for evaluation of cancer risk sponsored by monbusho (JACC study). J Epidemiol (2001) 2.20
The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis (2011) 2.19
Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci (2001) 2.19
Induction of pleomorphism in Lactobacillus bifidus. J Bacteriol (1968) 2.17
A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo. Nat Biotechnol (2000) 2.16
Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun (2001) 2.13
A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet (1999) 2.12
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol (2000) 2.11
Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol (2000) 2.09
Arteries in contact with the cisternal portion of the facial nerve in autopsy cases: microsurgical anatomy for neurovascular decompression surgery of hemifacial spasm. Surg Neurol (1990) 2.08
Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc Natl Acad Sci U S A (1990) 2.08
Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology (2001) 2.07
VEGF and flt. Expression time kinetics in rat brain infarct. Stroke (1996) 2.06
Moyamoya disease. Neuropathology (2000) 2.06
Magnetic resonance elastography of brain tumors: preliminary results. Acta Radiol (2007) 2.04
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer (2001) 2.01
Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels. J Biol Chem (2001) 1.99
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes (2001) 1.94
The Rop GTPase switch controls multiple developmental processes in Arabidopsis. Plant Physiol (2001) 1.93
Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res (1999) 1.93
Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg (2006) 1.91
A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology (1993) 1.90
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev (2000) 1.89
Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol (1999) 1.88
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation (2001) 1.86
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med (2001) 1.85
Use of the stomach as an esophageal substitute. Ann Surg (1978) 1.84
Polymer-assisted deposition of metal-oxide films. Nat Mater (2004) 1.83
Potassium channels from NG108-15 neuroblastoma-glioma hybrid cells. Primary structure and functional expression from cDNAs. FEBS Lett (1989) 1.82
Degradative capacities and 16S rRNA-targeted whole-cell hybridization of sulfate-reducing bacteria in an anaerobic enrichment culture utilizing alkylbenzenes from crude oil. Appl Environ Microbiol (1996) 1.82
Partial purification and characterization of UDPG:t-cinnamate glucosyltransferase in the root of sweet potato, Ipomoea batatas Lam. J Biochem (1984) 1.82
Sulfate-reducing bacteria and their activities in cyanobacterial mats of solar lake (Sinai, Egypt). Appl Environ Microbiol (1998) 1.79
Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res (2001) 1.78
B-raf, a new member of the raf family, is activated by DNA rearrangement. Mol Cell Biol (1988) 1.78
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol (2000) 1.76
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res (1995) 1.76
Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74
Intracranial penetrating injuries via the optic canal. AJNR Am J Neuroradiol (1998) 1.74
Optimization of annealing temperature to reduce bias caused by a primer mismatch in multitemplate PCR. Appl Environ Microbiol (2001) 1.73
Induction of pleomorphy and calcium ion deficiency in Lactobacillus bifidus. J Bacteriol (1970) 1.71
Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res (2000) 1.69
Purification and some properties of the endogenous, autolytic N-acetylmuramoylhydrolase of Streptococcus faecium, a bacterial glycoenzyme. J Biol Chem (1983) 1.69
A test of significance for geographic clusters of disease. Int J Epidemiol (1979) 1.68
Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol (2001) 1.67
A common position-dependent mechanism controls cell-type patterning and GLABRA2 regulation in the root and hypocotyl epidermis of Arabidopsis. Plant Physiol (1998) 1.67
Relation of spontaneous passage of ureteral calculi to size. Urology (1977) 1.67
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol (2009) 1.66